ClinicalTrials.gg
RecruitingNCT07692126Updated Jul 10, 2026

Core Stability vs Scapular Stabilization on Hand Grip Strength in Chronic Myofascial Neck Pain

An interventional study of Core Stability Exercise Protocol and Scapular stabilization Exercise Protocol in Myofascial Neck Pain, Hand Grip Strength and Pressure Pain Threshold, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Muscle Weakness with a site in Egypt — 4 open to participants now, 4 under way, none of them phase 3. Muscle Weakness · Egypt.

Started
2026
with 2 others
No phase
7 of 16
1 open now
Registered
14th of 16
by date
Lead sponsor
6 of 16
Cairo University

Among the 16 studies in Muscle Weakness with a site in Egypt, this one is one of 3 that started in 2026, is one of 7 with no phase, and was the 14th registered.

Muscle Weakness

478 studies on the registry are indexed under Muscle Weakness; 72 are open to participants now.

Browse Muscle Weakness studies →

Open to participants now

4 of the 16 studies in Muscle Weakness with a site in Egypt are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 52 Muscle Weakness studies recruiting now, 25 (48%) set no upper age limit and 20 (38%) stop at 75 or younger; 5 take children under 18; 18 take healthy volunteers.

This study: 25 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Muscle Weakness with a site in Egypt, or all of them as a file.
02

Study summary

Chronic myofascial neck pain (CMNP) is a painful non-articular musculoskeletal neck syndrome that is a persistent and prevalent with a high incidence of recurrence rate range 30-93%.Management of myofascial trigger points were directed at its deactivation, and prevention of its recurrence. Based on mechanical kinetic chain, the upper extremity functions as a unique system of connected segments those collaborated in a harmony in order to perform daily life activities. Core stability exercises maximize motor pathways mechanoreceptors' activities, as well scapular stabilization exercises are generally recommended based on reported benefits in terms of chronic neck pain. The relationship between chronic myofascial neck pain, and hand disability is quite strong. From mechanical point of view, core stability exercises improve trunk stability in line to enhance upper extremity efficiency that facilitates hand, and pinch grasping. In addition, scapular stabilization exercises could improve both hand, and pinch grasp strength and dexterity. Therefore, this randomized clinical trial will be conducted in line to clarify the superiority of the therapeutic effects between core stability exercises, scapular stabilization exercises, and conventional physical therapy program on hand grip strength, pinch grip strength, neck pain intensity level, pain pressure threshold, and whole upper extremity functional level in patients with chronic myofascial neck pain.

Read the detailed description

Chronic myofascial neck pain (CMNP) is a painful non-articular musculoskeletal neck syndrome that is a persistent and prevalent with a frequently reported myofascial trigger points (MTrPs) at upper trapezius with a reported prevalence of up to 93.75%. Individuals with upper trapezius MTrPs would have an overall upper extremity muscular strength reduction that ultimately resulting in decline hand grip strength. positive relation between core endurance and hand grip strength. That finding may be explained by the fact that the core region exhibits an anatomical, and biomechanical interconnection with the extremities, characterized by a prominent muscular linkage. Both core and scapular stabilization exercises has been addressed as one of the most evidence-based modalities. core acts as a the central most part of the kinetic chain, or a double walled cylinder with abdominals in front, multifidis as back, diaphragm as a roof, pelvic floor at the bottom. Where upper extremities connect with core, and attached extremities articulations that transfer energy from torso proximally to extremities' parts distally during functional activities . Scapular stability represents a vital role in terms of whole upper extremity functioning. The research gap to answer the question; Are there any significant differences between core stability exercises, scapular stabilization exercises, and conventional physical therapy program on hand grip strength, pinch grip strength, neck pain intensity level, pain pressure threshold, and whole upper extremity functional level in patients with chronic myofascial neck pain?

03

Conditions studied

  • Myofascial Neck Pain
  • Hand Grip Strength
  • Pressure Pain Threshold
  • Trigger Point in Trapezius Muscle
  • Core Muscle Weakness
  • Scapular Muscle Endurance
  • Disability of the Arm, Shoulder, and Hand Questionnaire
  • Neck Pain Musculoskeletal

Keywords

  • Core Stability Exercise
  • Scapular Stabilization Exercises
  • Hand Grip Strength
  • Chronic Myofascial neck syndrome
  • Trigger Points
  • Upper Trapezius
  • Pinch Grip Strength
  • Hand Held Dynamometer
  • Pressure Pain Threshold
  • Pressure Algometer
  • Diability of the Arm, Shoulder, and Hand Questionnaire (Arabic version), (Arabic-Q-DASH)
04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients diagnosed with chronic myofascial neck pain depending on referral, and physical examination.
  2. Sixty patients diagnosed with chronic myofascial neck pain for more than six months.
  3. Patients age range will 25-45 years
  4. Patients (BMI) will be 18.5-24.9 kg/m2
  5. Each patient suffering from all active MTrPs in the upper trapezius muscle with painful/ tender nodule.
  6. Patients have a constant neck pain with positive jump sign when palpating the upper trapezius muscle.
  7. Patients have referred pain, and symptoms of ipsilateral hand muscle weakness.
  8. No history of undergoing physiotherapy modalities or injection therapies in the past six months before the study

Exclusion criteria

Exclusion Criteria:

  1. Presence of signs of severe pathology such as , mainly of the cervical region.
  2. Fracture of the cervical spine.
  3. Cervical radiculopathy or myelopathy.
  4. Diabetes mellitus.
  5. Trauma, cognitive anomalies, and surgery around neck, shoulders, or hand.
  6. Fibromyalgia or vascular syndromes such as vertebral basilar insufficiency.
  7. Pregnancy.
  8. Having undergone physical therapy within the past three months before the study.
  9. Having injection therapies in the past 3 months before the study.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Experimental Group A (Core Stability)

    consists of 20 participants who receive core stability exercises, plus the traditional physical therapy program in the form of ischemic compression of upper trapezius muscle, strain-counter strain of upper trapezius muscle, and muscle energy technique of upper trapezius muscle, three sessions per week for 6 weeks.

    Other: Core Stability Exercise Protocol · Other: Traditional Physical Therapy Protocol

  • Experimental
    Experimental Group B (Scapular Stabilization)

    consists of 20 participants who receive scapular stabilization exercise, plus the traditional physical therapy program, three sessions per week for 6 weeks.

    Other: Scapular stabilization Exercise Protocol · Other: Traditional Physical Therapy Protocol

  • Active comparator
    Control Group C (Traditional Physical Therapy Program)

    consists of 20 participants who receive the traditional physical therapy program, three sessions per week for 6 weeks, only

    Other: Traditional Physical Therapy Protocol

Interventions

  • OtherCore Stability Exercise Protocol

    The core stability exercise protocol will be conducted to experimental group (A), only. The core stability exercise protocol will be conducted for 40-45 minutes (10 minutes worm-up 'stretch exercises', 25 minutes core stabilization exercises, and 5-10 minutes cool down exercises 'stretch exercises') 3 sections/ week for six weeks 1\. Diaphragm Core '';360 degree expansion breathing, weighted breathing 2. Transverse abdominis 'Abdominal drawing in maneuver, supine vacuum, pelvic tilt'; 3. Multifidus 'quadruped altered leg/arm, bridge with leg extension'; 4. Pelvic Floor muscles/Kegel, bridging, and bridging dog, and squat Core stability exercise.

  • OtherScapular stabilization Exercise Protocol

    The scapular stabilization exercise protocol will be conducted to experimental group (B), only. The core scapular stabilization exercise protocol will be conducted for 40-45 minutes (10 minutes worm-up 'stretch exercises', 25 minutes scapular stabilization exercises, and 5-10 minutes cool down exercises 'stretch exercises') 3 sections/ week for six weeks a. Open chain stabilization exercises 'scapular elevation/depression, upward/downward rotation', b. Static closed chain stabilization exercises 'Protected weight bearing through both hands leaning against wall', c. Dynamic closed chain stabilization exercises 'scapular retraction'

  • OtherTraditional Physical Therapy Protocol

    1. Ischemic compression; apply an intermittent ischemic compression on the identified MTrPs within upper trapezius via the researcher thumb for ninety seconds. 2. Strain-counter strain; apply pressure at MTrPs within stretched upper trapezius, with patient will move the affected shoulder passively to 90° of abduction and external rotation for ninety seconds. 3. Muscle Energy Technique; patient will do lateral neck flexion to opposite side, and will maintained for 10 seconds, will apply thirty seconds of stretch for ipsilateral affected upper trapezius

06

What researchers measure

Primary outcomes

  1. Hand Grip Strength

    Hand-held Dynamometer (SAMMONS PRESTON, INC. Bolingbrook, IL604404989) will be used to measure it. The patient will sit on a standard height chair with no armrest with his/ her forearm in a neutral position, and shoulder in adducted and neutral rotation, with elbow flexed 90 degrees (°). The patient will be requested to squeeze the ipsilateral hand on the hand grip dynamometer handle accordingly to the ordered verbs 'i.e., one, two, three, squeeze…harder, harder'. Three measures will be conducted with one minute a break in between, then the average will be recorded in value score.

    Time frame: 1. At Baseline (Pre-procedure), 2. Post-treatment (Post 6 weeks of treatment program).

  2. Pinch Grip Strength

    The pinch gauge (FEI, White plains, NY 10602, USA) will be used to measure the pinch grip strength, it is a valid and reliable tool. The patient will sit on a standard height chair with no armrest with his/ her shoulder, elbow, forearm, and wrist in a neutral position. The patient will be requested to squeeze the thumb pad as firm as possible against the lateral aspect of index fingers' middle phalanx, while the examiner will hold the distal end of the pinch gauge. Three measures will be conducted with one minute a break in between, then the average will be recorded in a score value.

    Time frame: 1. At Baseline (Pre-procedure), 2. Post-treatment (Post 6 weeks of treatment program).

Secondary outcomes

  1. Chronic Myofascial Neck Pain Intensity assessment using Numerical Pain Rating Scale:

    Numerical Pain Rating Scale will be used to assess chronic myofascial neck pain intensity, The patient will be in a relaxed position then will be given the appendix which contains numerical pain rating scale. It involves a 0-10 scale, where 0 represents "no pain" and 10 represents "the worst pain imaginable" The patient will be instructed to place a vertical mark on the line to indicate his/her pain.

    Time frame: 1. At Baseline (Pre-procedure), 2. Post-treatment (Post 6 weeks of treatment program).

  2. Pressure Pain Threshold using electronic pressure algometer

    The electronic pressure algometer 'force one gauge model FDI' (Wagner instruments, Greenwash, CT, USA) will be used to measure it, it is a valid and reliable tool. Over trigger point recognized via jump sign clinically, a dial-style pressure algometry will be installed while a steady vertical pressure will be applied. When the patient reported only mild pain, the patient will be asked to raise hand to indicate it. Three measures will be conducted with one minute a break in between, then average will be recorded in value.

    Time frame: 1. At Baseline (Pre-procedure), 2. Post-treatment (Post 6 weeks of treatment program).

  3. Whole Upper Extremity Functional Level using Arabic-Q-DASH scale

    The whole upper extremity functional level will be evaluated using Arabic-Q-DASH it is a valid and reliable tool. The Arabic-Q-DASH is like the original questionnaire. Items have a rating scale ranged from 1 to 5. The patient will be instructed to place a score that the examiner will transform it into a value between 0 and 100. The high score indicates better hand function outcomes with exception of pain, where high value indicates more intense pain score.

    Time frame: 1. At Baseline (Pre-procedure), 2. Post-treatment (Post 6 weeks of treatment program).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jan 2027, 7 months after the start.

Of 200 non-industry interventional studies with no phase under Muscle Weakness, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 7 months is below that.

Counting every sponsor, half of 212 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2026
First posted
Jul 9, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jun 30, 2027
Last update
Jul 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07692126
Lead sponsor
Cairo University
Responsible party
Adnan Abdelkhalik Atwa Gharib (Physical Therapy Specialist, Cairo University) — Principal investigator
First posted
Jul 9, 2026
Start date
Jun 1, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jul 10, 2026

Study contacts

Adnan AA Gharib, PHD
Contact
dradnanpts@gmail.com
+201065798861
Magda Ramadan Zahran, Assistant Professor
Contact
dradnanpts@gmail.com
01065798861
Sohair Shehata Rezkallah, Professor
study director · Cairo University; Faculty of Physical Therapy

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion